“KIRIN iMUSE Lactococcus Lemon Water” to Launch in Taiwan from June 24

TOKYO, June 24, 2026 - Kirin Beverage Company, Limited (Kirin Beverage) will launch “KIRIN iMUSE Lactococcus Lemon Water*1” containing Kirin’s proprietary ingredient L. lactic Plasma in Taiwan on Wednesday, June 24. This marks the first overseas export of a beverage manufactured by Kirin Beverage that contain L. lactic Plasma.
*1 KIRIN iMUSE | 1,000億LC-Plasma乳酸菌，調節生理機能

Within the Kirin Group’s Health Science business, expanding products containing L. lactic Plasma both domestically and internationally is positioned as one of the key initiatives addressing “health,” a priority issue under CSV*2 management. The beverage launch in Taiwan represents one such initiative to further broaden the application areas of L. lactic Plasma.
*2 Creating Shared Value. An approach that creates value for both consumers and society at large.

“KIRIN iMUSE Lactococcus Lemon Water” is a beverage developed by leveraging the expertise cultivated through the “iMUSE” brand, which has mainly been marketed in Japan, and contains L. lactic Plasma.
To date, the Company has exported and sold product series such as “Kirin Gogo-no-Kocha” and “Kirin Nama-cha” in Taiwan. In 2025, the combined sales volume of these series increased by approximately 30% year-on-year*3, achieving steady growth. By leveraging the proven track record and insights gained in the local market, the Company has decided to launch this product in Taiwan, with a view to further expanding distribution channels in the future.
*3 Based on the Kirin Beverage’s shipment volume from January to December 2025

About Kirin Holdings

Kirin Holdings Company, Limited is a global company operating across three core business domains spanning Alcoholic Beverages, Non-alcoholic Beverages & Health Science, and Pharmaceuticals. The company traces its roots to Japan Brewery, established in 1885, which later became Kirin Brewery in 1907. Since then, Kirin has expanded its business operations by leveraging fermentation and biotechnology as core strengths. The company entered the pharmaceutical field in the 1980s, which has since grown into a global business. In 2007, the company transitioned to a pure holding company structure as Kirin Holdings, and it is now strengthening its Non-alcoholic Beverages & Health Science domain.

Under its long-term vision “Innovate2035!”, the Kirin Group is focused on creating value that encourage behavioral change among consumers and patients, creating new lifestyle habits in the areas of food and health. With a unique business portfolio spanning Alcoholic Beverages, Non-alcoholic Beverages & Health Science, and Pharmaceuticals, the Group will further expand group-wide initiatives that support both mental and physical well-being.

The Kirin Group will continue to advance innovation through the combined strength of its people and technology, creating both social and economic value as a global leader in CSV*2, while pursuing sustainable, long-term growth in corporate value.